ERBB2 and breast cancer: In the primary analysis, fifteen microarray datasets with clinical information of BC patients classified as Luminal A (1168 cases), Luminal B (643 cases), HER2-enriched (359 cases), Basal-like (589 cases), and Normal-like (223 cases) were included in the meta-analysis.